Boehringer Ingelheim, a leading research-driven biopharmaceutical company, today announced a further expansion and upgrade of its plant in Koropi, Greece. With an investment of EUR 120 million, the company will increase the manufacturing capacity of new and existing medications. Main
A liquid compression system prototype at General Fusion’s Canadian labs RICHMOND, British Columbia, Jan. 11, 2024 (GLOBE NEWSWIRE) — General Fusion has published new, peer-reviewed scientific results that validate the company has achieved the smooth, rapid, and symmetric compression of
REGENETEN Patch 2024 First published randomized controlled trial for market-leading implant demonstrates impressive outcomes for rotator cuff tears Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces standout results for its REGENETEN Bioinductive Implant from a recently completed randomized
Quantexa to provide category-leading AI-enabled technology, training, and industry expertise to ATII to improve how data is used in the identification and investigation of human trafficking NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) — Today, Quantexa, a global leader in
Argentina’s Central Securities Depository (CSD) has successfully launched its new technology platform Rapidly accelerated launch timetable secures the platform’s ability to meet significant increase in volumes BUENOS AIRES, Argentina and NEW YORK, Jan. 11, 2024 (GLOBE NEWSWIRE) — Caja de